Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/07/071259
CTRI/2024/07/071259
Not Yet Recruiting
N/A

Evaluation of PotentialDrug-Drug Interactions in Patients AttendingMedicine OPD In a Tertiary Care Hospital of Eastern India- A Cross Sectional Study - NI

R G Kar Medical College and Hospital0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: Z922- Personal history of drug therapy

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: Z922- Personal history of drug therapy
Sponsor
R G Kar Medical College and Hospital
Status
Not Yet Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
R G Kar Medical College and Hospital

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients of age above 18 years attending
  • •Medicine OPD
  • •2\. 2 or more drugs prescribed

Exclusion Criteria

  • •1\. Drug abuse
  • •2\. Patients with poor adherence to therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
N/A
Assessing Potential Drug- Drug Interactions with Integrase Inhibitors in HIV patients.Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
CTRI/2022/02/040013Manipal Academy of Higher Education
Not Yet Recruiting
N/A
Analysis of possible interactions between different drugs in older adult patients with chronic kidney disease
CTRI/2024/08/072194Dr.Akshay Balakrishna
Completed
Phase 4
To study the nature,mechanism and common drug class involved in possible drug-drug interactions in emergency medicine department patients admitted for at least two days in emergency department wards.Health Condition 1: O- Medical and Surgical
CTRI/2020/01/022913Kempegowda Institute of Medical Sciences110
Completed
Phase 1
Evaluation of pharmacokinetic interactions between the antidiabetic metformin andthe antibiotic trimethoprim.E11.90
DRKS00000481niversität Heidelberg, Medizinische Fakultät24
Completed
Phase 1
Pharmacokinetic drug-drug interaction study between oral 300 mg netupitant/0.50 mg palonosetron fixed dose combination (Akynzeo®) and oral dexamethasone to evaluate the duration of the CYP3A4 inhibition in healthy subjectsInhibitory effect on CYP3A4Not Applicable
ISRCTN93845260Helsinn Healthcare SA24